S203: ABSCOPAL EFFECT OF RADIOTHERAPY AND NIVOLUMAB IN RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: PRE-PLANNED INTERIM ANALYSIS OF THE INTERNATIONAL GHSG PHASE II AERN TRIAL

• P. Bröckelmann,
• I. Bühnen,
• J. Zijlstra,
• A. Fossa,
• J. Meissner,
• S. Mathas,
• J. Rosenbrock,
• C. Kobe,
• M. Fuchs,
• A. Plütschow,
• S. Marnitz,
• P. Borchmann,
• A. Engert,
• C. Baues

Affiliations

P. Bröckelmann

1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University Hospital of Cologne

I. Bühnen

3 German Hodgkin Study Group (GHSG), University of Cologne

J. Zijlstra

5 Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, Netherlands

A. Fossa

6 Department of Oncology, Oslo University Hospital, Oslo, Norway

J. Meissner

7 Faculty of Medicine and University Hospital Heidelberg, Department V of Internal Medicine, University of Heidelberg, Heidelberg

S. Mathas

8 Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, and Experimental and Clinical Research Center (ECRC), Berlin

J. Rosenbrock

9 University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center

C. Kobe

10 Department of Nuclear Medicine

M. Fuchs

3 German Hodgkin Study Group (GHSG), University of Cologne

A. Plütschow

3 German Hodgkin Study Group (GHSG), University of Cologne

S. Marnitz

9 University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center

P. Borchmann

11 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine, Cologne, Germany

A. Engert

11 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine, Cologne, Germany

C. Baues

9 University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center